Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...

Healthy younger adults and children will no longer be automatically approved for annual COVID-19 vaccines under a new policy ...

Novavax originally showed its vaccine was safe and effective in a 30,000-person clinical trial. The FDA had been on track to ...

In a major policy change, the Food and Drug Administration has announced a plan to limit access to future COVID-19 shots only ...

The FDA has updated COVID-19 vaccine regulations. Only people aged 65 and up, along with certain groups, will be eligible to ...

The U.S. Food and Drug Administration approved Novavax's COVID-19 vaccine with age restrictions after a six-week delay.

The FDA has approved Novavax’s protein-based COVID-19 vaccine, giving some Americans another option besides messenger RNA ...

The FDA has updated COVID-19 vaccine regulations. Only people aged 65 and up, along with certain groups, will be eligible to receive booster shots. FDA officials are asking for more data around ...

The FDA is tightening its regulatory policy around COVID vaccines with a new framework that raises the bar for certain ...

Large, lengthy studies will be needed for the agency to approve boosters for healthy adults and children, regulators said.